| Symbol: |
TM2D2
|
| Description: |
TM2 domain containing 2 [Source:HGNC Symbol;Acc:24127]
|
| Location: |
Chr8:38846327-38854343[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:386
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| TM2D2 |
2-fluorphenylhydrazone alpha-lapachone |
0.001 |
Down |
| TM2D2 |
NSC 722876 |
0.004 |
Up |
| TM2D2 |
NSC 723548 |
0.006 |
Up |
| TM2D2 |
Pyridone-OCH3 |
0.001 |
Down |
| TM2D2 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.019 |
Down |
| TM2D2 |
NSC 724771 |
0.014 |
Up |
| TM2D2 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.035 |
Up |
| TM2D2 |
Dasatinib |
0.001 |
Down |
| TM2D2 |
NSC 732719 |
0.031 |
Up |
| TM2D2 |
Everolimus |
0.006 |
Down |
| TM2D2 |
NSC 734631 |
0.018 |
Up |
| TM2D2 |
6-(3-Azido-propyl)-2,3-dimethoxthy-5,11-dioxo-5,11-dihydro-6 H-indeno[1,2-c]isoquinoline-9-carbonitrile |
0.001 |
Down |
| TM2D2 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.002 |
Down |
| TM2D2 |
4-(4-Chloro-phenyl)-7a-methyl-2,5-diphenyl-7aH-cyclopenta[b] pyran-7-one |
0.004 |
Up |
| TM2D2 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.015 |
Up |
Expression pattern: Sensitivity / Resistance
Total:26 Current:24
First Prev Next Last
|
| SNP:
~ Export ~
|
Records:47
Total:4 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|